How a curcumin supplement is processed in healthy adults
Treatments studied
This study tests how a curcumin supplement (an extract from turmeric) moves through the body in healthy adults. It aims to see how the body processes it, which can help understand its effects and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You need a body mass index (a measure of weight versus height) between 18.5 and 30, with a minimum weight of about 110 pounds (50 kg) for men and about 100 pounds (45 kg) for women.
- You should be in good general health, without major medical conditions like heart, liver, kidney, or mental health disorders.
- You cannot be allergic to curcumin (found in turmeric) or have had allergic reactions to two or more drugs or foods.
- You must be willing to avoid certain substances, like alcohol, during the study, and if you smoke, you must smoke no more than 5 cigarettes a day on average.
- You need to be able to follow a standard diet and avoid certain supplements and foods that could affect how the supplement is absorbed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the safety and how the body processes a cannabis extract in healthy volunteers. It helps researchers understand if the extract is safe and how it works before moving to larger studies.
This trial tests whether a curcumin (turmeric) supplement can help women with advanced cervical cancer who are about to start standard treatment with chemotherapy and radiation. It aims to see if adding curcumin improves outcomes.
This trial tests whether taking turmeric for 8 weeks can improve overall health and well-being in healthy older adults. You'll take a turmeric supplement daily and have your health monitored.
This early-stage study tests whether curcumin (a natural plant compound) can affect eye changes in people who have amyloid deposits in the retina. It aims to see if the treatment is safe and possibly helpful for vision-related outcomes.
This study tests whether a curcumin (turmeric) suppository can safely treat anal precancerous changes called AIN 2 or AIN 3. It may be an option if you have high-grade cell changes and want to avoid more invasive treatments.
This study tests how a new investigational drug (called CM326) behaves in the body of healthy volunteers. It is a pharmacokinetic study, meaning it looks at how the drug is absorbed, distributed, and eliminated. Participation may help researchers understand the drug's safety and dosing for future studies.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.